Analyst Ratings for ABIOMED (ABMD) [Buys]
ABMD Rating Summary
ABMD Price Target Summary
- Highest: $28.00 (Jefferies)
- Lowest: $13.00 (Rodman & Renshaw)
- Average: $19.40
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$19.40 (-15.7%)
Avg. $ Target:
$19.40 (-15.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2013 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
17.38 | 23.00 | 32.34% | Details |
| 6/4/2012 | Lazard Capital | Upgrade | Buy (Neutral) |
N/A (N/A) |
18.91 | 23.00 | 21.63% | Details |
| 12/9/2011 | Stephens | New Coverage | Overweight (N/A) |
24.00 (N/A) |
19.91 | 23.00 | 15.52% | Details |
| 4/29/2011 | Baird | Upgrade | Outperform (N/A) |
N/A (N/A) |
16.55 | 23.00 | 38.97% | Details |
| 2/4/2011 | Jefferies » Updated 9/5/2012 |
Upgrade | Buy (N/A) |
28.00 (N/A) |
12.31 | 23.00 | 86.84% | Details |
| 12/9/2010 | Wunderlich Securities | New Coverage | Buy (N/A) |
N/A (N/A) |
9.25 | 23.00 | 148.65% | Details |
